Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Human CD16-AF700 (GRM1)

Cat. No.:
9570-27
Alexa Fluor® 700 Anti-Human CD16 antibody for use in flow cytometry assays.
$253.00
Size Price (USD) Quantity
100 tests $253.00
More Information
Clone GRM1
Isotype Mouse (BALB/c) IgG2aκ
Isotype Control Mouse IgG2a-AF700 (HOPC-1)
Specificity Human CD16
Alternative Names FcγRIII, low affinity Fc receptor
Description CD16, a member of the immunoglobulin superfamily, is a 50-65 kDa glycoprotein found as both a transmembrane and GPI-linked form. The transmembrane form of CD16 is expressed on NK cells, granulocytes, macrophages, and mast cells but not on eosinophils. The GPI-anchored type of CD16 is found only on neutrophils. CD16 is involved in NK activation and signal transduction.
Immunogen Mononuclear cells from a prolymphocytic B-leukemia
Conjugate AF700 (Alexa Fluor® 700)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Monoclonal
Concentration Lot specific
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Trademark Information Alexa Fluor® is a registered trademark of Thermo Fisher Scientific, Inc. or its subsidiaries
Applications Flow Cytometry – Quality tested 6
Immunohistochemistry-Frozen Sections – Reported in literature 3
Immunoprecipitation – Reported in literature 1,2
Western Blot – Reported in literature 3
ELISA – Reported in literature 4,5
Complement Mediated Cell Depletion – Reported in literature 1

RRID Number AB_2796958
Gene ID 2214 (Human)
Gene ID Symbol FCGR3A (Human)
Gene ID Aliases CD16; CD16A; FCG3; FCGR3; FCGRIII; FCR-10; FCRIII; FCRIIIA; IGFR3; IMD20
UniProt ID P08637 (Human
UniProt Name FCG3A_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Lopez-Nevot MA, Cabrera T, Huelin C, Ruiz-Cabello F, Garrido F. A study of mAb GRM1 which reacts with natural killer cells and granulocytes. In: McMichael AJ, Beverley PC, Cobbold S, Crumpton MJ, Gilks W, Gotch FM, et al, editors. Leukocyte Typing III: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1987. p. 707. (Immunogen, IP, CMDC)
  2. 2. Uggla CK, Jondal M, Kaplan D, Flomenberg N, Knowles RW. Enhancement of natural killer cell activity by unique antibodies within the CD2 (sheep-RBC receptor) and CD16 (Fc receptor) clusters. In: McMichael AJ, Beverley PC, Cobbold S, Crumpton MJ, Gilks W, Gotch FM, et al, editors. Leukocyte Typing III: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1987. p. 134-7. (IP)
  3. 3. Wainwright SD, Holmes CH. Distribution of Fcγ receptors on trophoblast during human placental development: an immunohistochemical and immunoblotting study. Immunology. 1993;80:343-51. (IHC-FS, WB)
  4. 4. Masuda M, Miyoshi H, Kobatake S, Nishimura N, Dong XH, Komiyama Y, et al. Increased soluble FcγRIIIa in plasma from patients with coronary artery diseases. Artherosclerosis. 2006;188:377-83. (ELISA)
  5. 5. Masuda M, Amano K, Hong SY, Nishimura N, Fukui M, Yoshika M, et al. Soluble FcγRIIIa levels in plasma correlate with carotid maximum intima-media thickness (IMT) in subjects undergoing an annual medical checkup. Mol Med. 2008;14:436-42. (ELISA)
  6. 6. Pilling D, Vakil V, Gomer RH. Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J Immunol Methods. 2009;351:62-70. (FC)
See All References